Viking Therapeutics is a clinical-stage biotech company focused on developing weight-loss therapies. Read why I rate VKTX ...

The NFL's decision to move the Rams-Vikings game marks just the second time the league's moved a playoff game in its 105-season history. While Monday's game is being moved for safety concerns ...

Tuesday, Viking ... to semaglutide before the 72-week mark noted in Novo Nordisk's trial. Pantginis highlighted the potential of both the oral and subcutaneous forms of VK2735, especially when ...

Novo Nordisk reported that adults with obesity achieved significant weight loss using their semaglutide ... CagriSema. The maintained Buy rating and price target reflect a positive outlook for ...

Conversely, Viking stock may be getting a boost because, although it works much like semaglutide and targets the same hormone semaglutide targets, the GLP-1 drug it is developing (but not yet ...